This company has been marked as potentially delisted and may not be actively trading. Chimerix (CMRX) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsBuy This Stock Chimerix Earnings Summary Chimerix announced Q4 2024 earnings on March 21, 2025, reporting an EPS of -$0.25, which beat analysts' consensus estimates of -$0.26 by $0.01. Quarterly revenue was reported to be $0.06 million, below the consensus estimate of $0.31 million. With a trailing EPS of -$0.99, Chimerix's earnings are expected to grow next year, from ($0.99) to ($0.85) per share. Upcoming Earnings DateAug. 11Before Market OpensEstimatedConsensus EPS (Mar. 21) -$0.26 Actual EPS (Mar. 21) -$0.25 Beat By $0.01 Actual Revenue (Mar. 21) $0.06MQ4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)SEC FilingCMRX Upcoming EarningsChimerix's next earnings date is estimated for Monday, August 11, 2025, based on past reporting schedules. Powered by Get Chimerix Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Chimerix and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCMRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CMRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Chimerix Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.29-$0.24-$0.27Q2 20252-$0.32-$0.27-$0.30Q3 20252-$0.33-$0.28-$0.31Q4 20252-$0.31$0.74$0.22 Chimerix Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/11/2025(Estimated)--------3/21/2025Q4 2024-$0.26-$0.25+$0.01-$0.25$0.31M$0.06M11/7/2024Q3 2024-$0.24-$0.26 -$0.02-$0.26$1.26M$0.03M8/13/2024Q2 2024-$0.23-$0.23--$0.23$1.26M$0.13M5/1/2024Q1 2024-$0.21-$0.25 -$0.04-$0.25$1.31M-2/29/2024Q4 2023-$0.23-$0.20+$0.03-$0.20--11/2/2023Q3 2023-$0.22-$0.27 -$0.05-$0.27$0.22M$0.01M8/3/2023Q2 2023-$0.23-$0.21+$0.02-$0.21$0.64M$0.03M Chimerix Earnings - Frequently Asked Questions When is Chimerix's earnings date? Chimerix has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based off last year's report dates. Learn more on CMRX's earnings history. Did Chimerix beat their earnings estimates last quarter? In the previous quarter, Chimerix (NASDAQ:CMRX) reported ($0.25) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.26) by $0.01. Learn more on analysts' earnings estimate vs. CMRX's actual earnings. How can I view Chimerix's earnings report? Chimerix's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Chimerix generate each year? Chimerix (NASDAQ:CMRX) has a recorded annual revenue of $212,000.00. How much profit does Chimerix generate each year? Chimerix (NASDAQ:CMRX) has a recorded net income of -$82.10 million. CMRX has generated -$0.99 earnings per share over the last four quarters. What is Chimerix's EPS forecast for next year? Chimerix's earnings are expected to grow from ($0.99) per share to ($0.85) per share in the next year. More Earnings Resources from MarketBeat Related Companies Immunovant Earnings Results Kymera Therapeutics Earnings Results Crinetics Pharmaceuticals Earnings Results Alvotech Earnings Results Mirum Pharmaceuticals Earnings Results Catalyst Pharmaceuticals Earnings Results AMNEAL PHARMACEUTICALS Earnings Results NewAmsterdam Pharma Earnings Results Ultragenyx Pharmaceutical Earnings Results Organon & Co. Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead?Amazon's Pre-Earnings Setup Is Almost Too Clean—Red Flag?Deckers Stock Recovers on Strong Earnings—More Upside Ahead?3 Reasons Tesla's Post-Earnings Hangover Looks Like a BuyCan Qualcomm Shock Wall Street With Its Q3 Earnings?T-Mobile Earnings Show You Why This Is a Stock to Hold This page (NASDAQ:CMRX) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThe Fed Just Froze You Out (Again)The Fed’s holding rates steady—again. No clarity. No yield. No relief. But one income strategy is quietly t...Investors Alley | SponsoredSomething BIG is about to hit the stock marketMost investors won’t see it coming—but Weiss Ratings says a major market event is brewing. Their system jus...Weiss Ratings | SponsoredThe $1 Trillion Event Tesla Still Hasn’t Recovered FromIn 2010, a “Flash Crash” erased $1 trillion in minutes. Now, one trading legend says it’s happening again—insi...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chimerix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chimerix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CMRX Stock Alerts